HYDERABAD, India--(BUSINESS WIRE)--Promius Pharma, LLC, a wholly owned subsidiary of Dr. Reddy’s Laboratories (NYSE:RDY) announced the launch of its first product, EpiCeram® Skin Barrier Emulsion. EpiCeram® Emulsion is a novel prescription therapy for the treatment of atopic dermatitis, a skin disease that affects more than 15 million patients in the United States.
